MENUNews Archive
Date: 10/28/2019
Ascentage Pharma Group International, co-founded by U-M faculty member Shaomeng Wang, Ph.D., is now trading on Hong Kong’s stock exchange after an initial public offering. The company develops new therapies for cancer and other diseases.
Date: 10/21/2019
University of Michigan Rogel Cancer Center member Gabriel Nuñez, M.D., is among the new members of the National Academy of Medicine of the National Academies, one of the highest honors in the fields of health and medicine. (The institute was formerly called the Institute of Medicine.)
Date: 10/21/2019
This 'Cancer Moonshot' research grant has been awarded to the University of Michigan's Dental School. Dr. Yu Leo Lei, a Rogel Cancer Center member, will lead researchers from U-M, other universities on new cancer prevention therapies.
Date: 10/18/2019
Some of the most important players on a cancer patient’s health care team are people they typically never meet or interact with -- the pathologists.
Date: 10/10/2019
A U-M Rogel Cancer Center study found aggressive breast cancer cells stored high amounts of energy which enabled them to spread. This suggests a potential target in the metabolism that could slow or prevent breast cancer metastasis.
Date: 10/07/2019
At present, some patients have samples of their cancer cells grown in mice for drug testing and analysis, but the cancer cells don’t always grow and the process takes months.
Date: 10/05/2019
The majority of patients in the study thought it was important to conduct medical research using de-identified electronic health records. Support for academic medical centers or community hospitals seeking to improve quality was high, but fewer people were comfortable with insurance companies or drug companies using their data, as well as hospitals using their data for marketing purposes.
Date: 10/01/2019
Changing the way individuals are selected to be screened for lung cancer could prevent 14% of lung cancer deaths per year.
Date: 09/24/2019
The University of Michigan Rogel Cancer Center and the Barbara Ann Karmanos Cancer Institute at Wayne State University have received a prestigious $9.2 million grant from the National Cancer Institute for prostate cancer research.
Date: 09/15/2019
A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men.